Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Ticklel1ston Apr 15, 2019 4:44pm

112 Views

Post# 29629905

RE:RE:RE:New week

EngcantLL..this is Vancouver. Chris Verrico was a director of Sirona..yes Howie's brother.. and he sold shares into news when the company was starting out. We were buying shares. Infact, I may have boght soeme of Chris's shares. Many unhappy investors after that.

But, it is vancouver and one should not expect a high standard...similar to Howie's videos...which I wish he would remove from the Sirona website. So very amature when trying to play in the world market.

Bullboard Posts

Corus reports Q1 profit drop in the face of falling revenue